You are here

taldefgrobep alfa

Biohaven fails phase 3 SMA test but plans talks with FDA, plots move into obesity

Fierce Biotech

Mon, 11/25/24 - 11:22 am

taldefgrobep alfa

spinal muscular atrophy

Biohaven looks to seize a new opportunity

EP Vantage

Thu, 02/9/23 - 10:33 am

taldefgrobep alfa

Intercept, Annovis and Biohaven Advance Late Phase Trials

BioSpace

Mon, 07/11/22 - 12:00 am

Intercept Pharma NASH

Parkinson's Disease

taldefgrobep alfa